Bernardo Cortese

Summary

Publications

  1. ncbi request reprint Transient left ventricular apical ballooning syndrome: all that glitters is not apical
    Bernardo Cortese
    Servizio di Emondinamica, Ospedali del Tigullio Lavagna, Lavagna, Italy
    J Cardiovasc Med (Hagerstown) 8:934-6. 2007
  2. doi request reprint Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientific data
    Bernardo Cortese
    Interventional Cardiology, Fatebenefratelli Hospital, Milan, Italy Fondazione Monasterio CNR Regione Toscana, Italy Electronic address
    Int J Cardiol 220:589-94. 2016
  3. doi request reprint Final shape of biovascular scaffolds and clinical outcome. Results from a multicenter all-comers study with intravascular imaging
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli, Milano, Italy Electronic address
    Int J Cardiol 228:209-213. 2017
  4. ncbi request reprint Performance of bioresorbable vascular scaffolds versus cobalt-chromium everolimus-eluting stent in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a review of currently available clinical data
    Dario Buccheri
    Azienda Ospedaliera Fatebenefratelli, Milan, Italy
    Minerva Cardioangiol 64:74-83. 2016
  5. doi request reprint Registro Absorb Italiano (BVS-RAI): an investigators-owned and -directed, open, prospective registry of consecutive patients treated with the Absorb™ BVS: study design
    Bernardo Cortese
    Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milano Electronic address
    Cardiovasc Revasc Med 16:340-3. 2015
  6. ncbi request reprint Late Malapposition After Bare-Metal Stent, But Not Bioresorbable Scaffold: Insights on Intraindividual Heterogeneity in Plaque and Device Response
    Bernardo Cortese
    Fatebenefratelly Hospital, Corso di Porta Nuova 23, 20121 Milano, Italy
    J Invasive Cardiol 27:E171-2. 2015
  7. doi request reprint Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left With a Dissection
    Bernardo Cortese
    Cardiac Department, A O Fatebenefratelli, Milano, Italy Electronic address
    JACC Cardiovasc Interv 8:2003-9. 2015
  8. doi request reprint Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions
    Bernardo Cortese
    Department of Interventional Cardiology, A O Fatebenefratelli, Milano, Italy Electronic address
    Am J Cardiol 116:705-10. 2015
  9. doi request reprint Comparison of risk of acute kidney injury after primary percutaneous coronary interventions with the transradial approach versus the transfemoral approach (from the PRIPITENA urban registry)
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli Milano, Milano, Italy Electronic address
    Am J Cardiol 114:820-5. 2014
  10. doi request reprint Safety and feasibility of iliac endovascular interventions with a radial approach. Results from a multicenter study coordinated by the Italian Radial Force
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli Milano, Italy Electronic address
    Int J Cardiol 175:280-4. 2014

Collaborators

Detail Information

Publications51

  1. ncbi request reprint Transient left ventricular apical ballooning syndrome: all that glitters is not apical
    Bernardo Cortese
    Servizio di Emondinamica, Ospedali del Tigullio Lavagna, Lavagna, Italy
    J Cardiovasc Med (Hagerstown) 8:934-6. 2007
    ..We add a small piece to the complicated puzzle represented by this syndrome...
  2. doi request reprint Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientific data
    Bernardo Cortese
    Interventional Cardiology, Fatebenefratelli Hospital, Milan, Italy Fondazione Monasterio CNR Regione Toscana, Italy Electronic address
    Int J Cardiol 220:589-94. 2016
    ..We review here the currently available scientific data and future perspectives on drug-coated balloon use for bifurcation lesions. ..
  3. doi request reprint Final shape of biovascular scaffolds and clinical outcome. Results from a multicenter all-comers study with intravascular imaging
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli, Milano, Italy Electronic address
    Int J Cardiol 228:209-213. 2017
    ..Moreover, their final shape patterns, when implanted in an all-comer, unselected population, have not yet been completely correlated with clinical outcome and should be better investigated...
  4. ncbi request reprint Performance of bioresorbable vascular scaffolds versus cobalt-chromium everolimus-eluting stent in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a review of currently available clinical data
    Dario Buccheri
    Azienda Ospedaliera Fatebenefratelli, Milan, Italy
    Minerva Cardioangiol 64:74-83. 2016
    ..However, we deem necessary a direct comparison between the two technologies, assessing hard clinical endpoints. ..
  5. doi request reprint Registro Absorb Italiano (BVS-RAI): an investigators-owned and -directed, open, prospective registry of consecutive patients treated with the Absorb™ BVS: study design
    Bernardo Cortese
    Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milano Electronic address
    Cardiovasc Revasc Med 16:340-3. 2015
    ..Instruments are needed to collect, share and assess the experience being accumulated with this new device in several centres...
  6. ncbi request reprint Late Malapposition After Bare-Metal Stent, But Not Bioresorbable Scaffold: Insights on Intraindividual Heterogeneity in Plaque and Device Response
    Bernardo Cortese
    Fatebenefratelly Hospital, Corso di Porta Nuova 23, 20121 Milano, Italy
    J Invasive Cardiol 27:E171-2. 2015
    ..This case highlights the potential heterogeneity in the evolution of atherosclerotic plaques and response to different devices in the same patient. ..
  7. doi request reprint Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left With a Dissection
    Bernardo Cortese
    Cardiac Department, A O Fatebenefratelli, Milano, Italy Electronic address
    JACC Cardiovasc Interv 8:2003-9. 2015
    ..The authors sought to understand the clinical and angiographic outcomes of dissections left after drug-coated balloon (DCB) angioplasty...
  8. doi request reprint Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions
    Bernardo Cortese
    Department of Interventional Cardiology, A O Fatebenefratelli, Milano, Italy Electronic address
    Am J Cardiol 116:705-10. 2015
    ..Larger and adequately powered randomized trials are needed to fully assess the potential clinical benefit of BVS versus the current standard of care in patients with STEMI. ..
  9. doi request reprint Comparison of risk of acute kidney injury after primary percutaneous coronary interventions with the transradial approach versus the transfemoral approach (from the PRIPITENA urban registry)
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli Milano, Milano, Italy Electronic address
    Am J Cardiol 114:820-5. 2014
    ..084 to 2.524, p = 0.042). In conclusion, in this database of primary PCI, the risk of AKI was lower with a TR approach, and the TF approach was an independent predictor for the occurrence of this complication...
  10. doi request reprint Safety and feasibility of iliac endovascular interventions with a radial approach. Results from a multicenter study coordinated by the Italian Radial Force
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli Milano, Italy Electronic address
    Int J Cardiol 175:280-4. 2014
    ..This route has not yet been well studied for the majority of peripheral interventions, like those involving the iliac arteries. In this study we sought to evaluate the feasibility and safety of this approach for iliac interventions...
  11. doi request reprint Paclitaxel coated balloons, the time for awareness has come
    Bernardo Cortese
    Scientific Research Director, Interventional Cardiology, Humanitas Gavazzeni, Bergamo, Italy Electronic address
    Int J Cardiol 164:1-2. 2013
    ..As these technologies emerge, we hope that some of the lessons learned will bring to proper validation strategies and solid experimental and clinical experimentations...
  12. doi request reprint Transradial percutaneous iliac intervention, a feasible alternative to the transfemoral route
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli, Bastioni diPorta Nuova 21, Milan, Italy
    Cardiovasc Revasc Med 13:331-4. 2012
    ..However, this route has not yet been well studied for the majority of peripheral interventions, like those involving the iliac arteries...
  13. doi request reprint Drug-eluting stents perform better than bare metal stents in small coronary vessels: a meta-analysis of randomised and observational clinical studies with mid-term follow up
    Bernardo Cortese
    Interventional Cardiology, Ospedale Humanitas Gavazzeni, Bergamo, Italy
    Int J Cardiol 161:73-82. 2012
    ..We tested drug-eluting stent (DES) and bare metal stent (BMS) performance in small coronary vessels by means of meta-analysis of all available clinical studies...
  14. doi request reprint Paclitaxel coated balloons for coronary artery interventions: a comprehensive review of preclinical and clinical data
    Bernardo Cortese
    Interventional Cardiology, Cliniche Humanitas Gavazzeni, Bergamo, Italy
    Int J Cardiol 161:4-12. 2012
    ..We will comment on this topic trying to understand the reasons of this failure, and will discuss on possible future developments and applications for these devices for the treatment of coronary artery disease...
  15. ncbi request reprint Bivalirudin has its own shelf in the cath lab, eventually
    Bernardo Cortese
    Interventional Cardiology, Humanitas Gavazzeni, Bergamo, Italy Electronic address
    Int J Cardiol 160:153-4. 2012
    ..Newer well designed studies or ones with newer infusion modalities have contributed to dispel the doubts making this drug particularly fit for the catheterization laboratory...
  16. ncbi request reprint In the bivalirudin era, are we still looking for a potent antiplatelet agent?
    Bernardo Cortese
    Interventional Cardiology, Cliniche Humanitas Gavazzeni, Via Gavazzeni 37, Bergamo, Italy
    Curr Vasc Pharmacol 10:476-8. 2012
    ..In this article, we discuss on the most recent studies on this drug in the catheterization laboratory during acute myocardial infarction...
  17. doi request reprint Coronary bifurcation lesions: innovative approaches and the future of bifurcation devices
    Bernardo Cortese
    Interventional Cardiology, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, Italy
    Future Cardiol 6:221-30. 2010
    ..Here, we review the main technical features of this stent class and all the scientific data available...
  18. doi request reprint Intracoronary bivalirudin for no reflow reversal: a second chance to treat this disorder?
    Bernardo Cortese
    Interventional Cardiology, Ospedale della Misericordia, Grosseto, Italy
    J Thromb Thrombolysis 28:74-6. 2009
    ..We showed how bivalirudin, a drug whose use is increasing in the catheterization laboratories, could be safely used via the intracoronary route to treat no reflow phenomenon due to distal microembolization in a complex patient...
  19. ncbi request reprint A new technique for the treatment of bifurcation lesions: modified reverse crushing
    Bernardo Cortese
    Cardiologia Interventistica, Ospedale di Grosseto, Italy
    Indian Heart J 60:605-7. 2008
    ..We present the case of a 69-year-old male suffering an acute myocardial infarction and undergoing primary PCI of a bifurcation lesion...
  20. ncbi request reprint Combined, superselective pharmacological management of large coronary thrombus burden
    Bernardo Cortese
    Cardiovascular Department, Misericordia Hospital, Grosseto, Italy
    J Invasive Cardiol 21:168-71. 2009
    ..A large inter-patient variability is often observed, and large randomized trials failed to demonstrate any clear benefit of such mechanical strategies on clinical outcome...
  21. doi request reprint Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study
    Bernardo Cortese
    Interventional Cardiology Unit, Ospedale della Misericordia, Grosseto, Italy
    Coron Artery Dis 20:348-53. 2009
    ..Although the approved labeling for bivalirudin allows for low-dose prolonged postprocedure administration, this practice is not routine. Therefore, we sought to evaluate the safety and efficacy of longer post-PCI infusion...
  22. doi request reprint Acute mesenteric ischemia: primary percutaneous therapy
    Bernardo Cortese
    Interventional Cardiology Unit, Ospedale della Misericordia, Grosseto, Italy
    Catheter Cardiovasc Interv 75:283-5. 2010
    ..Management of acute mesenteric ischemia is still a matter of concern for physicians. This disorder has been associated to an increased mortality mainly because of a late diagnosis and controversial treatment options...
  23. doi request reprint The PICCOLETO study and beyond
    Bernardo Cortese
    Interventional Cardiology, Cliniche Humanitas Gavazzeni, Bergamo, Italy
    EuroIntervention 7:K53-6. 2011
    ..After the excellent results of the PACCOCATH ISR and PEPCAD II trials in in-stent restenosis, paclitaxel-coated balloon (PCB) still has to prove its efficacy in native coronary disease...
  24. doi request reprint Effect of prolonged Bivalirudin infusion on ST-segment resolution following primary percutaneous coronary intervention (from the PROBI VIRI 2 study)
    Bernardo Cortese
    Interventional Cardiology, Cliniche Humanitas Gavazzeni, Bergamo, Italy
    Am J Cardiol 108:1220-4. 2011
    ..In conclusion, a strategy of prolonged bivalirudin infusion after primary PCI seems equivalent to a strategy with heparin plus abciximab, with an improvement in standard infusion in obtaining early microvascular reperfusion...
  25. doi request reprint Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris
    Bernardo Cortese
    Interventional Cardiology Unit, Ospedale della Misericordia, Grosseto, Italy
    Am J Cardiol 104:1063-8. 2009
    ..In conclusion, in patients undergoing complex PCI, a prolonged bivalirudin infusion after PCI compared to an intraprocedural-only regimen significantly decreased the incidence of periprocedural myocardial damage...
  26. doi request reprint Rationale and design of the randomized, multicenter EREMUS trial, a study that investigates how to achieve low restenosis and early reendothelialization after percutaneous coronary interventions
    Bernardo Cortese
    Interventional Cardiology, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milano, Italy
    Catheter Cardiovasc Interv 78:32-7. 2011
    ..Thus, the availabilily of different approaches with comparable efficacy to DES, but higher safety, especially in bleeding-prone patients, have to be investigated...
  27. doi request reprint Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study
    Bernardo Cortese
    Interventional Cardiology Unit, Cardiovascular Department, Ospedale della Misericordia, Grosseto, Italy
    Heart 96:1291-6. 2010
    ..The impact of a PCB during PCI of small coronary vessels was evaluated and compared to one of the most widely used DES...
  28. doi request reprint Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience
    Elisabetta Moscarella
    From the Department of Cardio Thoracic Science, Second University of Naples, Presidio Ospedaliero Monaldi, Azienda Ospedaliera Dei Colli, Napoli, Italy E M Cardiology Division, Azienda Ospedaliera Bolognini Seriate, Bergamo, Italy A I, M T Laboratory of Invasive Cardiology, Santa Maria della Pietà Hospital, Nola, Napoli, Italy F G, L C, A V Cardiovascular Intervention Unit, San Martino Hospital, Belluno, Italy S C Laboratory of Invasive Cardiology, Dipartimento di Scienze Biomediche Avanzate, Universita degli Studi Federico II, Napoli, Italy E S Interventional Cardiology Unit, EMO GVM Centro Cuore Columbus ed Ospedale San Raffaele, Milano, Italy A L, A T, A C Laboratory of Invasive Cardiology, Azienda Ospedaliera Fatebenefratelli, Milano, Italy B C and Laboratory of Invasive Cardiology, Department of Cardiology, Presidio Ospedaliero Monaldi, Azienda Ospedaliera Dei Colli, Napoli, Italy C C
    Circ Cardiovasc Interv 9:e003148. 2016
    ..In this setting, the use of bioresorbable vascular scaffold (BVS) seems attractive because it allows drug delivery combined with transient vessel scaffolding. We aimed to investigate the long-term results after BVS use in ISR lesions...
  29. doi request reprint Acute ST-elevation myocardial infarction in a 15-year-old boy with celiac disease and multifactorial thrombotic risk
    Andrea Picchi
    Department of Cardiology, Misericordia Hospital, Grosseto, Italy
    Thromb Haemost 99:1116-8. 2008
  30. doi request reprint Usefulness of primary angioplasty in nonagenarians with acute myocardial infarction
    Gian Battista Danzi
    Divisione di Cardiologia, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan, Italy
    Am J Cardiol 106:770-3. 2010
    ..The treatment does not affect the poor prognosis of patients presenting with cardiogenic shock, but the administration of abciximab seems to have a positive effect on 6-month mortality...
  31. doi request reprint Increased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients
    Andrea Picchi
    Department of Cardiology, Misericordia Hospital, Grosseto, Italy
    Am J Physiol Heart Circ Physiol 301:H2279-84. 2011
    ..Basal coronary flow relates to insulin resistance, suggesting a key role of cellular metabolism in the regulation of coronary blood flow...
  32. doi request reprint Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry
    Roberto Adriano Latini
    Interventional Cardiology, Azienda Ospedaliera Fatebenefratelli, Milano, Italy
    Catheter Cardiovasc Interv 88:380-7. 2016
    ..In this study, we investigated long-term results following bioresorbable vascular scaffold (BVS) implantation in small coronary arteries...
  33. doi request reprint Contrast-enhanced sonography in the diagnosis of acute mesenteric ischemia: case report
    Andrea Giannetti
    Department of Gastroenterology, Misericordia Hospital, Grosseto, Italy
    J Clin Ultrasound 38:156-60. 2010
    ..We report the case of an 87-year-old woman with acute mesenteric ischemia, in whom contrast-enhanced sonography visualized the occluded superior mesenteric artery and the infarcted portion of the intestine...
  34. doi request reprint Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing A
    Andrea Picchi
    Misericordia Hospital, Grosseto, Italy
    EuroIntervention 10:1311-7. 2015
    ..The aim of this study is to test whether a strategy of prolonged bivalirudin infusion may reduce thrombosis of stent struts as compared to an intraprocedural only administration in subjects undergoing primary PCI...
  35. doi request reprint Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship
    Ugo Limbruno
    aCardiology Unit, Misericordia Hospital, Grosseto bInterventional Cardiology, A O Fatebenefratelli, Milan cInstitute of Cardiology and Center of Excellence on Aging, G D Annunzio University, Chieti, Italy
    J Cardiovasc Med (Hagerstown) 15:587-94. 2014
    ..We established a quantitative method to selectively evaluate the dose-dependent nephrotoxic effect of different contrast agents...
  36. doi request reprint Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli Milano, Italy
    Catheter Cardiovasc Interv 83:427-35. 2014
    ..This Position Paper represents a quick reference for operators, investigators, and manufactures to promote the understanding and the correct use of the drug-coated balloon technology in everyday clinical practice...
  37. doi request reprint Distal embolisation during carotid stenting is predicted by circulating levels of LDL cholesterol and C-reactive protein
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli, Milan, Italy
    EuroIntervention 10:513-7. 2014
    ..Our aim was to find patient characteristics which are associated with a higher risk of embolisation during CAS...
  38. doi request reprint Thrombectomy for thrombus removal, filters for whatever else
    Ugo Limbruno
    Interventional Cardiology, Misericordia Hospital, Grosseto, Italy
    J Cardiovasc Med (Hagerstown) 9:408-9. 2008
    ....
  39. ncbi request reprint Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors
    Marco De Carlo
    Cardiology Unit, Cardiothoracic Department, University of Pisa, Italy
    Int J Cardiol 123:229-33. 2008
    ....
  40. doi request reprint Recurrent in-stent restenosis, certainty of its origin, uncertainty about treatment
    Davide Piraino
    Interventional Cardiology, P Giaccone University Hospital of Palermo, Italy Electronic address
    Int J Cardiol 230:91-96. 2017
    ..In this setting, we present a review of the literature about this interesting topic, going deep into the heart of the problem, its origin and possible treatment options...
  41. pmc Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment
    Dario Buccheri
    Interventional Cardiology, Paolo Giaccone Hospital, Palermo, Italy Interventional Cardiology, Fatebenefratelli Hospital, Milano, Italy Cardiology Department, San Giacomo D Altopasso Hospital, Licata Agrigento, Italy
    J Thorac Dis 8:E1150-E1162. 2016
    ..We here review the main characteristics of this common complication of coronary interventions, from its pathogenesis to the most appropriate treatment strategy...
  42. doi request reprint Effective Treatment of Intermediate-Risk Pulmonary Embolism by Manual Thrombus Aspiration. A Report of Two Cases
    Rodrigo Sebik
    Interventional Cardiology, A O Fatebenefratelli, Milano, Italy
    Heart Lung Circ 24:e130-2. 2015
    ..Currently, there's no clear and effective treatment for these patients, thus we believe that this therapy, as current ESC guidelines suggest, should become a possible alternative to systemic thrombolysis and anticoagulant regimen. ..
  43. doi request reprint Drug-eluting stent use after coronary atherectomy: results from a multicentre experience - The ROTALINK I study
    Bernardo Cortese
    aUnit of Interventional Cardiology, A O Fatebenefratelli, Milan bDepartment of Interventional Cardiology, Ospedale Mauriziano Umberto I, Torino cDepartment of Cardio Thoracic Vascular Department, San Raffaele Institute, Milan dDepartment of Interventional Cardiology, Spedali Civili, Brescia eDepartment of Interventional Cardiology, Cliniche Humanitas, Milan fDepartment of Interventional Cardiology, Ospedale Moriggia Pelascini, Gravedona, Italy
    J Cardiovasc Med (Hagerstown) 17:665-72. 2016
    ..Until now, there is no medium- to long-term clinical evidence of the best treatment after rotational atherectomy...
  44. pmc Bioresorbable vascular scaffolds in patients with acute myocardial infarction: a new step forward to optimized reperfusion?
    Fernando Alfonso
    1 Cardiology Department, Hospital Universitario de la Princesa, Madrid, Spain 2 Cardiac Department, A O Fatebenefratelli, Milano, Italy 3 Deutsches Herzzentrum München, Technische Universitat Munchen, Munich, Germany 4 DZHK German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Munich, Germany
    J Thorac Dis 8:E417-23. 2016
    ..Further studies, powered for clinical endpoints, are required to establish the relative safety and efficacy of BVS vs. new-generation metallic drug-eluting stents (DES) in patients with ST-segment elevation acute MI. ..
  45. doi request reprint First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis
    Roberto Adriano Latini
    Department of Interventional Cardiology, ASST Fatebenefratelli Sacco, Milan, Italy
    Catheter Cardiovasc Interv . 2016
    ..This case can provide an alternative treatment option in this setting, avoiding potential problems related to further bulky metallic stents in a patient where a different strategy was initially planned. © 2016 Wiley Periodicals, Inc...
  46. doi request reprint Late coronary BVS malapposition and aneurysm: A Time for Appraisal
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli Milano, Italy
    Catheter Cardiovasc Interv 86:678-81. 2015
    ..We here describe two cases that recently occurred in our patients, and we speculate on possible mechanisms for this unexpected and potentially lethal complication...
  47. doi request reprint The conundrum of antithrombotic drugs before, during and after primary PCI
    Bernardo Cortese
    Interventional Cardiology, A O Fatebenefratelli, Milan, Italy
    EuroIntervention 10:T64-73. 2014
    ....
  48. doi request reprint Design of the rosuvastatin pretreatment to reduce embolization during Carotid Artery Stenting trial
    Marco De Carlo
    aCardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero Universitaria, Pisana bInterventional Cardiology, A O Fatebenefratelli, Milan cCliniche Humanitas Gavazzeni, Bergamo dCardioangiology Unit, Cardiothoracic and Vascular Department, Azienda Ospedaliero Universitaria, Pisana, Italy
    J Cardiovasc Med (Hagerstown) 15:595-600. 2014
    ..Statin use has been demonstrated to reduce atherosclerotic plaque burden, but its effect in reducing distal embolization during carotid stenting has not yet been well validated...
  49. doi request reprint Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registry
    Marco De Carlo
    Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy
    Catheter Cardiovasc Interv 72:196-203. 2008
    ..The aim of this study was to investigate the safety and efficacy of an innovative thrombectomy device, the Rinspiration System, which simultaneously "rinses" the vessel with turbulent flow and aspirates thrombus...
  50. ncbi request reprint Coronary embolization of a proximal vessel due to retrieval of a balloon catheter with an organized thrombus during primary PCI
    Bernardo Cortese
    Int J Cardiol 123:e1-2. 2007
  51. ncbi request reprint Successful treatment of acute myocardial infarction due to subocclusive thrombosis over a small atherosclerotic plaque with the "Rinspiration" device, a novel thrombectomy catheter
    Marco De Carlo
    Int J Cardiol 115:95-6. 2007